© 1995 Oxford University Press
OTHER |
A widespread amino acid polymorphism at codon 905 of the glycogen-associated regulatory subunit of protein phosphatase-1 is associated with insulin resistance and hypersecretion of insulin
Steno Diabetes Center and Hagedorn Research Institute Copenhagen 1The Glostrup Population Studies, Medical Department C. Glostrup Hospital, University of Copenhagen Denmark 2Medical Research Council Protein Phosphorylation Unit, Department of Biochemistry, The University of Dundee Scotland, UK
*To whom correspondence should be addressed
Received January 11, 1995; Revised May 18, 1995; Accepted May 18, 1995
The regulatory G-subunit of the glycogen-associated form of protein phosphatase 1 (PP1) plays a crucial part in muscle tissue glycogen synthesis and breakdown. As impaired insulin stimulated glycogen synthesis in peripheral tissues is considered to be a pathogenic factor in subsets of non-insulin-dependent diabetes mellitus (NIDDM) and obesity, the G-subunit of PP1 should be viewed as a candidate gene for inherited insulin resistance. When applying heteroduplex formation analysis and nucleotide sequencing of PP1G-subunit cDNA from 30 insulin resistant white NIDDM patients two cases were identified as heterozygous carriers of an Asp905
Tyr substitution. The carrier prevalence of the PP1G-subunit variant was 18% in 150 healthy subjects and 13% in 313 NIDDM subjects (x2 = 1.94, p = 0.16). Twenty-seven healthy subjects volunteered for a 4 h euglycaemic, hyperinsulinaemic clamp in combination with indirect calorimetry in order to elucidate the potential impact of the Tyr905 substitution on the whole body glucose metabolism. Interestingly, the Tyr905 variant was associated with altered routing of glucose: a decreased insulin stimulated non-oxidative glucose metabolism of peripheral tissues (glycogen synthesis) (p<0.04) and an increased basal glucose oxidation rate (p<0.04) when compared with wild type carriers. A population-based sample of 380 unrelated young healthy Caucasians was examined during a combined intravenous glucose and tolbutamide test to address whether the Asp905/Tyr905 polymorphism was associated with alterations in insulin secretion which might be secondary to the insulin resistance of skeletal muscle. First phase insulin secretion was unaffected in lean carriers of the codon 905 polymorphism whereas obese carriers of the variant PP1G allele had a 42% (p<0.003) higher first phase insulin response when compared with matched obese wild-type carriers. In conclusion: (i) a widespread PP1G-subunit Asp905 /Tyr905 polymorphism offers the first major contribution to explain the genetics behind the large variation in insulin-stimulated muscle glycogen synthesis in the general Caucasian population; (ii) the PP1G variant and obesity interact to elicit a postglucose hypersecretion of insulin; and (iii) the findings substantiate the concept that a single genetically determined tissue-specific (skeletal muscle) and pathway-specific (glycogen synthesis) insulin resistance is not by itself sufficient to increase the risk of developing NIDDM.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. An, B. I. Freedman, S. S. Rich, S. A. Mandel, D. K. Arnett, R. H. Myers, Y.-D. I. Chen, S. C. Hunt, and D.C. Rao Quantitative Trait Loci on Chromosome 8q24 for Pancreatic {beta}-Cell Function and 7q11 for Insulin Sensitivity in Obese Nondiabetic White and Black Families: Evidence From Genome-Wide Linkage Scans in the NHLBI Hypertension Genetic Epidemiology Network (HyperGEN) Study Diabetes, February 1, 2006; 55(2): 551 - 558. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Bouche, S. Serdy, C. R. Kahn, and A. B. Goldfine The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes Endocr. Rev., October 1, 2004; 25(5): 807 - 830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Lakka, T. Rankinen, S. J. Weisnagel, Y. C. Chagnon, T. Rice, A. S. Leon, J. S. Skinner, J. H. Wilmore, D.C. Rao, and C. Bouchard A Quantitative Trait Locus on 7q31 for the Changes in Plasma Insulin in Response to Exercise Training: The HERITAGE Family Study Diabetes, June 1, 2003; 52(6): 1583 - 1587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Delibegovic, C. G. Armstrong, L. Dobbie, P. W. Watt, A. J.H. Smith, and P. T.W. Cohen Disruption of the Striated Muscle Glycogen Targeting Subunit PPP1R3A of Protein Phosphatase 1 Leads to Increased Weight Gain, Fat Deposition, and Development of Insulin Resistance Diabetes, March 1, 2003; 52(3): 596 - 604. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Liolitsa, J Powell, and S Lovestone Genetic variability in the insulin signalling pathway may contribute to the risk of late onset Alzheimer's disease J. Neurol. Neurosurg. Psychiatry, September 1, 2002; 73(3): 261 - 266. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Elbein Perspective: The Search for Genes for Type 2 Diabetes in the Post-Genome Era Endocrinology, June 1, 2002; 143(6): 2012 - 2018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Echwald, H. Bach, H. Vestergaard, B. Richelsen, K. Kristensen, T. Drivsholm, K. Borch-Johnsen, T. Hansen, and O. Pedersen A P387L Variant in Protein Tyrosine Phosphatase-1B (PTP-1B) Is Associated With Type 2 Diabetes and Impaired Serine Phosphorylation of PTP-1B In Vitro Diabetes, January 1, 2002; 51(1): 1 - 6. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Suzuki, C. Lanner, J.-H. Kim, P. G. Vilardo, H. Zhang, J. Yang, L. D. Cooper, M. Steele, A. Kennedy, C. B. Bock, et al. Insulin Control of Glycogen Metabolism in Knockout Mice Lacking the Muscle-Specific Protein Phosphatase PP1G/RGL Mol. Cell. Biol., April 15, 2001; 21(8): 2683 - 2694. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. K. Rasmussen, C. Lautier, L. Hansen, S. M. Echwald, T. Hansen, C. T. Ekstrøm, S. A. Urhammer, K. Borch-Johnsen, F. Grigorescu, R. J. Smith, et al. Studies of the Variability of the Genes Encoding the Insulin-Like Growth Factor I Receptor and Its Ligand in Relation to Type 2 Diabetes Mellitus J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1606 - 1610. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. Ragolia, N. Duddy, and N. Begum Effect of an Asp905Tyr Mutation of the Glycogen-Associated Regulatory Subunit of Protein Phosphatase-1 on the Regulation of Glycogen Synthesis by Insulin and Cyclic Adenosine 3',5'-Monophosphate Agonists Mol. Endocrinol., October 1, 1999; 13(10): 1773 - 1783. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. Kohno, S. Takakura, T. Yamada, A. Okamoto, T. Tanaka, and J. Yokota Alterations of the PPP1R3 Gene in Human Cancer Cancer Res., September 1, 1999; 59(17): 4170 - 4174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Hegele, S. B. Harris, B. Zinman, J. Wang, H. Cao, A. J. G. Hanley, L.-C. Tsui, and S. W. Scherer Variation in the AU(AT)-Rich Element within the 3'-Untranslated Region of PPP1R3 Is Associated with Variation in Plasma Glucose in Aboriginal Canadians J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3980 - 3983. [Abstract] [Full Text]
|
|
|
|
 |
|
 G.-Q. Shen, H. Ikegami, T. Fujisawa, Y. Hamada, K. Kamide, H. Rakugi, J. Higaki, H. Murakami, K. Shimamoto, and T. Ogihara Asp905Tyr Polymorphism of Protein Phosphatase 1 G Subunit Gene in Hypertension Hypertension, August 1, 1997; 30(2): 236 - 239. [Abstract] [Full Text]
|
|
|
|
|
|
L. Ragolia and N. Begum The Effect of Modulating the Glycogen-Associated Regulatory Subunit of Protein Phosphatase-1 on Insulin Action in Rat Skeletal Muscle Cells Endocrinology, June 1, 1997; 138(6): 2398 - 2404. [Abstract] [Full Text] [PDF]
|
|